Fingerprint
Dive into the research topics of 'Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial
Maria L. Elkjaer*, Rikke M. Lohse, Mark Burton, Jason P. Mendoza, Mads Thomassen, Tobias Sejbaek, Zsolt Illes
*Corresponding author for this work
- KI, OUH, Research unit of Neurology (Odense)
- Department of Clinical Research
- KI, BRIDGE - Brain Research - Inter Disciplinary Guided Excellence (Odense)
- Department of Molecular Medicine
- Neurobiology Research Unit
- KI, OUH, Clinical Genome Center (Odense)
- KI, OUH, Research unit of Clinical Genetics (Odense)
- Department of Regional Health Research
- IRS - Esbjerg and Grindsted Hospital, Research Unit of Neurology (Esbjerg)
Research output: Contribution to journal › Journal article › Research › peer-review
40
Downloads
(Pure)